ABPI
Boehringer and Sanofi admit to code breaches
February 13, 2015Medical Communications, Sales and Marketing ABPI, Boehringer, PMCPA, Sanofi, afatinib, giotrif
Sanofi and Boehringer Ingelheim have both admitted to breaching the ABPI Code of Practice, with Sanofi set to be publicly …
New president for ABPI
February 9, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Amgen, Pfizer, Whitehead, emms, john kearney
The Association of the British Pharmaceutical Industry has appointed John Kearney as its new president. Stepping into the role in …
Stephen Whitehead: pharma has transformed
February 2, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, CDF, NHS, NICE, PPRS, Stephen Whitehead, lgbt, pharma
According to The Association of the British Pharmaceutical Industry (ABPI) the dominant issue in 2015 will be the affordability and …
George Freeman – a US blog
January 27, 2015Medical Communications, Sales and Marketing ABPI, Cameron, Kaiser Permanente, Obama, george freeman, google, life sciences
It is a privilege to have been appointed as the first ever minister for life sciences.I’m determined to ensure that …
ABPI appoints Amgen director to innovation role
January 27, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Amgen, Bina Rawal, Virginia Acha
The Association of the British Pharmaceutical Industry (ABPI) has named Dr Virginia Acha as its new executive director of Research …
GSK double complaint ruled out by PMCPA
January 16, 2015Medical Communications, Sales and Marketing ABPI, COPD, GSK, PMCPA, Relvar, Seretide
Complaints questioning the promotion of two of GlaxoSmithKline’s chronic obstructive pulmonary disease (COPD) drugs have been ruled out by a …
Boehringer complaint ruled out by PMCPA
January 15, 2015Medical Communications, Sales and Marketing ABPI, Boehringer, COPD, PMCPA, Striverdi, olodaterol
A complaint made by a pharmacist stating that the artwork image for Boehringer Ingelheim’s COPD drug Striverdi is misleading has …
Visions for the future: FT pharma and biotech event
December 19, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2020, ABPI, Deloitte, Medidata, Whitehead, financial ties, freeman, ft pharma
The FT Global Pharmaceutical and Biotechnology Conference held in London recently asked: “What will the life science company of the …
Government plans £6 billion precision medicine strategy
December 18, 2014Research and Development, Sales and Marketing ABPI, Cell Therapy Catapult, Ebola, George Osborne, UK, government
The government has committed to a £6 billion investment in scientific research and development as part of its science and …
PPRS scheme payment percentage to rise by 6.62% in 2015
December 12, 2014Sales and Marketing ABPI, PPRS, VBP, Whitehead, government, medicines bill
The amount of payment due from pharma via the PPRS scheme for next year has been confirmed by the Department …
Merck and Galderma breach ABPI code
December 8, 2014Medical Communications, Sales and Marketing ABPI, Erbitux, Galderma, PMCPA, merch
Merck Serono and Galderma will be named in advertisements as guilty of the most serious breach of the ABPI Code …
ABPI appoints first manufacturing director
December 8, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, James Christie
The Association of the British Pharmaceutical Industry (ABPI) has appointed James Christie to the newly-created position of project director for …
Government seeks stakeholder consultation over NICE
December 4, 2014Sales and Marketing ABPI, NHS, NICE, UK, emms, freeman, government, ndpb
NICE stakeholders are being asked for their views on its future as part of the government’s ongoing review into the …
ABPI director jumps ship to EFPIA
December 4, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, EFPIA, Whitehead, andrew powrie-smith, andrew-powrie-smith
ABPI director Andrew Powrie-Smith is leaving the body to join The European Federation of Pharmaceutical Industries and Associations (EFPIA) as …
George Freeman: UK pharma is vital for our landscape
December 1, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS, UK, WHO, freeman, medicine, stratified
The ABPI says the UK has an opportunity to benefit from stratified medicine, and the body’s 2014 conference held in …
Latest content
FibroFind appoints Lee Borthwick as CEO
